Can Eltrombopag be reimbursed by medical insurance?

Eltrombopag/Eltrombopag (Eltrombopag) is a drug that treats thrombocytopenia. It belongs to a class of drugs called thrombopoietin receptor agonists, which increase the number of platelets by stimulating stem and precursor cells in the bone marrow, promoting the production and release of platelets. Eltrombopag/Eltrombopagis commonly used to treat adult and pediatric patients with idiopathic thrombocytopenic purpura (ITP) and thrombocytopenia associated with chronic liver disease.

Eltrombopag/Eltrombopag has been launched in China and is included in medical insurance. Because medical insurance policies vary from place to place, the price after reimbursement is also different. For details, please consult the local hospital pharmacy or medical insurance bureau. EltrombopagEltrombopag/Eltrombopag is available abroad as both original and generic drugs. The original drugs include the Turkish original drug and the Indian version of the original drug. The prices of the two are almost the same, about more than 1,000 yuan. There are many versions of generic drugs, including those from India, Bangladesh, and Laos. The cheaper generic drug is Eltrombopag from Everest Pharmaceuticals in Bangladesh, which costs around a few hundred yuan. Other generic drugs are around one to two thousand yuan, and the ingredients of the original drug and the generic drug are basically the same.

Idiopathic thrombocytopenic purpura (ITP) is an immune disease characterized by the body's immune system mistakenly attacking and destroying its own platelets, resulting in low platelets and an increased risk of bleeding. Eltrombopag/Eltrombopag can help increase the number of platelets, thereby reducing the patient's bleeding symptoms.

It is important to note that drug use involves individual circumstances and physician advice, so you should consult your physician for professional advice before using eltrombopag/eltrombopag or any drug.